| Key takeaways from ESC Congress 2023 |
| Cardiac CT before TAVR detects CAD with high accuracy, suggesting a reduced need for invasive imaging |
| Seeds for weight loss recalled: FDA says they are a ‘highly toxic’ plant containing cardiac glycosides |
| Statin use after a bleeding stroke linked to key risk reductions |
| How monitoring MR can help cardiologists anticipate TAVR outcomes in patients with low-flow, low-gradient AS |
| Immediate vs. staged multivessel PCI: How the 2 strategies compare when treating STEMI patients |
| First 10 drugs chosen by White House for Medicare price negotiations include blood thinners, heart failure meds |
| Cardiologists detail long-term outcomes of valve-in-valve TMVR |
| Pulsed-field ablation as safe and effective as thermal ablation when treating paroxysmal AFib |
| FDA clears new smart scale capable of detecting AFib, other cardiovascular issues |
| Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms |
| Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations |
| Texas researchers receive $1.14M to develop first CVD drug of its kind |
| Weight loss drug semaglutide linked to multiple benefits for heart failure patients |
| Siemens Healthineers unveils 'truly revolutionary' AI-enabled echo system |
| ESC Congress 2023: 4 key sessions scheduled for world’s largest gathering of cardiology professionals |
| FDA panel votes not to endorse Medtronic renal denervation system |
| Beloved cardiologist Albert Waldo remembered for his lasting impact on electrophysiology |
| FDA panel votes in favor of Recor Medical renal denervation system |
| Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD |
| TAVR safe and effective for severe AS patients with a very low gradient |
| Interventional echocardiography expected to grow thanks to new structural heart procedures |
| How to deal with workplace bullying and discrimination in cardiology |
| Chest pain one year after a heart attack linked to lower odds of survival |
| Key government policies impacting cardiac ultrasound |
| Mitigating risk: How the depth of device implantation impacts LAAO outcomes |
| ESC Congress 2023 to feature 30 late-breaking clinical trials |
| Abiomed recalls heart pump catheter labeling after 12 injuries |
| FDA announces yet another recall, the fifth of 2023, for troubled heart devices |
| Interventional echocardiographers play a key role in the treatment of structural heart disease |
| AI spots critical heart defects missed by the human eye |
| FDA clears 2 new AI models that help with the diagnosis and treatment of arrhythmias |
| 2 key reasons the use of AI in echocardiography is growing |
| New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes |
| Weight loss drug semaglutide could boost heart health of up to 93M patients in US alone |
| AI model for HCM, the first of its kind, gains FDA approval |
| Starting salaries in cardiology down 10% as other specialties thrive |
| Shockwave Medical, the subject of recent acquisition rumors, announces $650M private offering |
| Alternative TAVR techniques: How to proceed when transfemoral access is not recommended |
| Microplastics identified in heart tissue samples—are surgeries to blame? |
| Interventional cardiologists call out ABIM for ‘unfair and unjustified’ certification policies |
| FDA announces fourth recall of 2023 for troubled heart devices |
| FDA highlights importance of including heart rhythm risks on drug labels |
| Relaxed fasting instructions prior to TAVR, other heart procedures do not affect outcomes |
| Surgery, interventional therapies still the best choice for many HCM patients |
| FDA approves Boston Scientific’s new cryoablation system for AFib |
| How medical imaging helps cardiologists treat hypertrophic cardiomyopathy |
| A surgeon's perspective on treating hypertrophic cardiomyopathy |
| Surgeon sues hospital after being fired for discussing TAVR concerns with media |
| Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients |
| Why hypertrophic cardiomyopathy may be widely underdiagnosed |
| Colchicine before PCI: New research tracks the long-term impact on heart health |
| NFL player feeling thankful after AFib diagnosis: ‘I think it’s just the good Lord looking after me’ |
| Cardiologist William C. Roberts remembered as a ‘true legend in cardiovascular medicine’ |
| FDA approves several Biosense Webster devices for fluoroscopy-free ablation procedures |
| New research on AI-based CCTA assessments wins Best Abstract at SCCT 2023 |
| More consistency, standardization still needed when treating HCM |
| Cardiologists applaud WHO’s endorsement of polypills for CVD prevention |
| Expanding Medicaid linked to better care for heart patients |
| Hypertrophic Cardiomyopathy Association has helped advance HCM care |
| Do infections cause heart attacks? Lessons from COVID |
| The 25 best U.S. cardiology hospitals ranked |
| Key trends and takeaways in cardiac CT at SCCT 2023 |
| Chinese made version of JenaValve TAVR device implanted in first patient |
